← Open Payments lookup

ASHLEY FITZHUGH: Open Payments

NPI 1356980817 · JACKSON, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,230 in 49 payments from 11 companies in 2025. Trend: 2023 $793 · 2024 $1,140 · 2025 $1,230

Food & beverage: $1,230
CompanyPaymentsAmount
GlaxoSmithKline, LLC.11$308
Merck Sharp & Dohme LLC8$207
Eisai Inc.4$183
Genmab U.S., Inc.5$124
ABBVIE INC.5$93
AstraZeneca Pharmaceuticals LP5$86
Caris MPI, Inc.3$55
VERTEX PHARMACEUTICALS INCORPORATED3$54
Myriad Genetic Laboratories, Inc.2$54
Astellas Pharma US Inc2$42

Products named: JEMPERLI, Lenvima, KEYTRUDA, LYNPARZA, ELAHERE, Tivdak, MI CANCER SEEK, JOURNAVX.

Industry payments across MS — which companies pay providers there.